The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded”

Cancer Policy

Kennedy overhauls “too woke” USPSTF with the appointment of eight members

U.S. cancer death rate declined 35% since 1991, AACR Cancer Progress Report finds

Cancer centers continue to face recurring drug shortages, NCCN survey finds

Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series

FDA’s expedited IND pilot aims to shorten the timeline between drug development and first-in-human clinical trials

Heidi Overton selected as FDA commissioner; Jared Seehafer named inaugural Deputy Commissioner for Technology and AI

Clinical Roundup

ASCO expresses support for functional precision medicine, rescinding past objections

EGFR mutation linked to dramatically increased lung cancer risk

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

UT Southwestern scientists discover metabolite fueling aggressive brain tumor growth

OST-HER2-treated patients show statistically significant benefit in interim three-year OS analysis of phase IIb pulmonary metastatic osteosarcoma trial

In The Clinic

mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented

FreeGuest Editorial
Guest Editorial
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account